Jazz Pharma (NASDAQ: JAZZ) director may sell 3,507 shares
Rhea-AI Filing Summary
Jazz Pharmaceuticals plc (JAZZ) had a Form 144 filed indicating that director Jennifer E. Cook may sell up to 3,507 shares of Jazz common stock under Rule 144. The shares relate to restricted stock vesting dated 08/28/2026, with an indicated aggregate market value of $857,602.00, to be sold through E*TRADE Financial on NASDAQ.
Positive
- None.
Negative
- None.
Key Figures
Shares potentially to be sold: 3,507 shares
Aggregate market value: $857,602.00
Rule 144 date related to vesting: 08/28/2026
+2 more
5 metrics
Shares potentially to be sold
3,507 shares
Common stock covered by Rule 144 notice for Jennifer E. Cook
Aggregate market value
$857,602.00
Value for 3,507 Jazz Pharmaceuticals plc common shares
Rule 144 date related to vesting
08/28/2026
Date of restricted stock vesting identified as source of shares
Form 144 signature date
08/31/2026
Date associated with the remarks and signature section
CUSIP-like identifier
64914577
Identifier listed for Jazz Pharmaceuticals plc common stock
Key Terms
Rule 144, restricted stock vesting, Form 144, power of attorney
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"COMMON | 08/28/2026 | RESTRICTED STOCK VESTING | ISSUER"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Form 144 regulatory
"144: Filer Information 144: Issuer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
power of attorney regulatory
"Signature | /s/Paz Dizon by power of attorney for Jennifer E. Cook"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
FAQ
What does the Form 144 filing for JAZZ disclose?
It discloses that Jennifer E. Cook, a director of Jazz Pharmaceuticals plc, may sell up to 3,507 shares of Jazz common stock pursuant to Rule 144, with the shares arising from restricted stock vesting dated 08/28/2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.